AF
STIM icon

Amalgamated Financial’s Neuronetics STIM Stock Holding History

Amalgamated Financial’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$12K Buy
+4,043
New +$13.7K ﹤0.01% 2863

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Amalgamated Financial's STIM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Neuronetics (STIM) in Q1 2022: 4,043 shares worth $12K. The stake represents ﹤0.01% of the portfolio and ranks #2863 among its holdings.

83 funds tracked by Wall St. Rank hold STIM as of Q1 2022.

  • Amalgamated Financial held 4,043 shares of Neuronetics worth $12K as of Q1 2022.
  • Neuronetics was a new Amalgamated Financial position in Q1 2022.
  • Neuronetics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2863 holding.
  • 83 funds tracked by Wall St. Rank held Neuronetics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.